MADISON, Wis., January 6, 2026 – Elephas Biosciences Corporation (Elephas), a privately held leader in precision oncology, today announced the publication of a foundational paper in Journal of Translational Medicine . The paper demonstrates how the Elephas Live™ Platform enables live tumor profiling for immunotherapy response prediction by analyzing cytokine activity in live tumor fragments (LTFs). This pioneering approach provides real-time insights into how individual tumors react to immunotherapy.
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules